BTW App for Reckless Driving
(BTW Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to find out if a phone app can help the learning-to-drive process among teenagers and novice drivers.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the BTW app treatment for reckless driving?
Is the BTW App for Reckless Driving safe for humans?
How does the BTW app treatment for reckless driving differ from other treatments?
The BTW app treatment is unique because it uses reward-based feedback and situational supervised driving practice to improve driving behavior, which is different from traditional methods that may not incorporate real-time feedback or incentives. This approach is similar to telematics-based interventions that provide real-time feedback and financial incentives to reduce speeding, but the BTW app specifically targets reckless driving with a focus on behavior modification through rewards and supervised practice.69101112
Research Team
Motao Zhu, MD,MS,PhD
Principal Investigator
Nationwide Children's Hospital
Eligibility Criteria
This trial is for teen drivers aged 15.5-17 who've completed a driver's ed class, have at least 50 hours of driving experience including night time, and have held their permit for 6 months. They need a smartphone compatible with the BTW app, must not join other driving studies, speak English, and have parental consent plus car insurance.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the BTW app to track and improve driving behaviors over a 6-month period
Follow-up
Participants are monitored for long-term effects on driving performance and safety attitudes
Treatment Details
Interventions
- BTW app with reward-based feedback
- BTW app with situational supervised driving practice
- Sham BTW app
Find a Clinic Near You
Who Is Running the Clinical Trial?
Motao Zhu
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator